Efficacy and safety of pembrolizumab in combination with olaparib in previously treated recurrent cervical cancer: An open-label, single-arm, phase II studyJohn P. Diaz, Manmeet S. Ahluwalia, E.D. Schroeder et al.|Gynecologic Oncology|2025Cited by 0